Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krynica Vitamin's change in receivables for the quarter that ended in Mar. 2026 was zł-14.1 Mil. It means Krynica Vitamin's Accounts Receivable
increased by zł14.1 Mil
from Dec. 2025 to Mar. 2026 .
Krynica Vitamin's change in receivables for the fiscal year that ended in Dec. 2025 was zł16.1 Mil. It means Krynica Vitamin's Accounts Receivable
declined by zł16.1 Mil
from Dec. 2024 to Dec. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Krynica Vitamin's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 50.11.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Krynica Vitamin's liquidation value for the
three
months ended in Mar. 2026 was zł-59.9 Mil.
Krynica Vitamin (WAR:KVT) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Krynica Vitamin's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krynica Vitamin Change In Receivables Related Terms
Krynica Vitamin Change In Receivables Historical Data
* Premium members only.
The historical data trend for Krynica Vitamin's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-3.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of zł-3.0 Mil mean?
Krynica Vitamin (WAR:KVT) has a Change In Receivables of zł-3.0 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Krynica Vitamin and its competitors.
Is Krynica Vitamin's Change In Receivables too high?
Krynica Vitamin's current Change In Receivables is zł-3.0 Mil. Overall, Krynica Vitamin has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krynica Vitamin's Change In Receivables compare to KO and PEP?
Krynica Vitamin's Change In Receivables of zł-3.0 Mil can be compared against companies in the Beverages - Non-Alcoholic industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Beverages - Non-Alcoholic company?
A good Change In Receivables depends on the Beverages - Non-Alcoholic industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Krynica Vitamin and its competitors. Krynica Vitamin's current Change In Receivables is zł-3.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krynica Vitamin stock overvalued right now?
Based on GuruFocus' analysis, Krynica Vitamin (WAR:KVT) is currently considered Modestly Overvalued. The stock's GF Value™ is zł10.39, compared to a current price of zł13.25 — trading 27.5% above its estimated fair value. The current Change In Receivables is zł-3.0 Mil. Krynica Vitamin's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Krynica Vitamin (WAR:KVT), the current Change In Receivables is zł-3.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krynica Vitamin (WAR:KVT) Overvalued in 2026?
Based on GuruFocus' analysis, Krynica Vitamin stock appears to be overvalued.
The current stock price of zł13.25 is trading 27.5% above its estimated GF Value™ of zł10.39.
GuruFocus considers Krynica Vitamin to be Modestly Overvalued.
Key valuation signals for WAR:KVT:
Change In Receivables: zł-3.0 Mil
GF Value™: zł10.39 vs. price of zł13.25 (27.5% above fair value)
No single metric tells the full story. See the WAR:KVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krynica Vitamin SA is a Polish producer of non-alcoholic and low-alcoholic beverages. The company is engaged in producing beverages for own brands and providing bottling services for brand-name products. It offer includes functional and energy drinks such as isotonic and hypotonic drinks, beverages that support metabolism, and diet supplementary vitamin drinks. It also offers functional waters, modern mixed-fruit drinks, drinks with fruit pulp, alcopops, ciders, malt beverages and a wide selection of carbonated beverages.
70GF Score
Get the complete analysis for WAR:KVT
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:KVT has been successfully added to your 
